Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase

International Journal of Cardiology

Volumn 97, Issue 2, 2004, Pages 221-224

  Srivathsan, Komandoor ^a   Showalter, John ^a   Wilkens, James ^a   Hurley, Brian ^a   Abbas, Amr ^a   Loutfi, Hassan ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute coronary syndrome; Creatine phosphokinase; Hospitalization; Myocardial infarction; Troponin

Indexed keywords

CREATINE KINASE; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SURVIVAL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TROPONIN I;

EID: 4644221341     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.08.018     Document Type: Article

References (23)

1. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N. Engl. J. Med. 335:1996;1342-1349
2. Braunwald E., Antman E., Beasley J., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). 2002;American College of Cardiology, Bethesda, MD
3. Klootwijk P., Hamm C. Acute coronary syndromes: diagnosis. Lancet. 353(Suppl. 2):1999;S1110-S1115
4. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N. Engl. J. Med. 335:1996;1333-1341
5. Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur. Heart J. 21:2000;1502-1513
6. Muller-Bardorff M., Freitag H., Scheffold T., Remppis A., Kubler W., Katus H.A. Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation. 92(10):1995;2869-2875
7. Adams J.E. III, Bodor G.S., Davila-Roman V.G., et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation. 88:1993;101-106
8. Cummins P., Young A., Auckland M.L., Michie C.A., Stone P.C.W., Shepstone B.J. Comparison of serum cardiac specific troponin-I with creatine kinase, creatine kinase-MB isoenzyme, tropomyosin, myoglobin and C-reactive protein release in marathon runners: cardiac or skeletal muscle trauma? Eur. J. Clin. Invest. 17:1987;317-324
9. The EPIC Investigators Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N. Engl. J. Med. 330:1994;956-961
10. The EPILOG Investigators Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N. Engl. J. Med. 336:1997;1689-1696
11. EPISTENT Investigators Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 352:1998;87-92
12. The IMPACT II Investigators Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet. 349:1997;1422-1428
13. The RESTORE Investigators Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation. 96:1997;1445-1453
14. Topol E.J., Serruys P.W. Frontiers in interventional cardiology. Circulation. 98:1998;1802-1820
15. Hamm C.W., Heeschen C., Goldmann B., et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N. Engl. J. Med. 340:1999;1623-1629
16. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N. Engl. J. Med. 344:2001;1879-1887
17. Ravkilde J., Horder M., Gerhardt W., et al. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand. J. Clin. Lab. Invest. 53:1993;677-685
18. Lindahl B., Venge P., Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 93:1996;1651-1657
19. Armstrong P.W., Chiong M.A., Parker J.O. The spectrum of unstable angina: prognostic role of serum creatine kinase determination. Am. J. Cardiol. 49:1982;1849-1852
20. White R.D., Grande P., Califf L., Palmeri S.T., Califf R.M., Wagner G.S. Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in suspected acute myocardial infarction. Am. J. Cardiol. 55:1985;1478-1484
21. Clyne C.A., Medeiros L.J., Marton K.I. The prognostic significance of immunoradiometric CK-MB assay (IRMA) diagnosis of myocardial infarction in patients with low total CK and elevated MB isoenzymes. Am. Heart J. 118:1989;901-906
22. Aviles R.J., Askari A.T., Lindahl B., et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N. Engl. J. Med. 346:2002;2047-2052
23. Douketis J.D., Crowther M.A., Stanton E.B., et al. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Arch. Intern. Med. 162:2002;79-81